KORU MEDICAL SYSTEMS, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M | $23.2M |
| Cost of Revenue | — | $15.5M | $12.3M | $11.8M | $12.5M | $9.7M | $9.2M | $8.3M |
| Gross Profit | — | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M | $14.9M | $14.9M |
| Gross Margin | — | 62.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% |
| Operating Expenses | ||||||||
| Research & Development | — | $4.4M | $5.3M | $5.7M | $5.0M | $2.5M | $1.3M | $740.5K |
| SG&A Expense | — | $23.4M | $21.6M | $20.4M | $20.6M | $17.9M | $12.0M | $9.8M |
| Operating Income | — | $-3.0M | $-6.4M | $-10.3M | $-10.8M | $-7.0M | $-1.3M | $585.7K |
| Operating Margin | — | -7.2% | -19.2% | -36.0% | -38.6% | -29.9% | -5.2% | 2.5% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-2.6M | $-6.1M | $-9.8M | $-10.7M | $-6.4M | $1.2M | $696.4K |
| Income Tax Expense | — | $21.9K | $2.9K | $4.0M | $-2.0M | $-1.8M | $-17.8K | $132.1K |
| Net Income | — | $-2.6M | $-6.1M | $-13.7M | $-8.7M | $-4.6M | $-1.2M | $564.3K |
| Net Margin | — | -6.4% | -18.0% | -48.2% | -31.0% | -19.4% | -5.0% | 2.4% |
| EPS (Basic) | — | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 | $0.01 |
| EPS (Diluted) | — | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 | $0.01 |
| Shares Outstanding (Basic) | 46.4M | 46.2M | 45.8M | 45.6M | 45.0M | 44.4M | 41.9M | 38.8M |
| Shares Outstanding (Diluted) | 46.4M | 46.2M | 45.8M | 45.6M | 45.0M | 44.4M | 41.9M | 39.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |